Third Pole Therapeutics
Medical Devices, 309 Waverley Oaks Rd Ste 404, Waltham, Massachusetts, 02452, United States, 11-50 Employees
Phone Number: 18*********
Who is THIRD POLE THERAPEUTICS
Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our teams legacy in inhaled nitric oxide (NO), the current stan...
Read More
-
Headquarters: 309 Waverley Oaks Rd Ste 404, Waltham, Massachusetts, 02452, United States
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
Industry: Medical Devices
SIC Code: 2834
|
NAICS Code: 541720 |
Show More
Does something look wrong? Fix it. | View contact records from THIRD POLE THERAPEUTICS
Third Pole Therapeutics Org Chart and Mapping
Email
Phone
Similar Companies to Third Pole Therapeutics
Abiomed
-
1001-5000
-
$ 1 Billion and Over
Insulet Corporation
-
1001-5000
-
$ 1 Billion and Over
Medtronic
-
10001+
-
$ 1 Billion and Over
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Third Pole Therapeutics
Answer: Third Pole Therapeutics's headquarters are located at 309 Waverley Oaks Rd Ste 404, Waltham, Massachusetts, 02452, United States
Answer: Third Pole Therapeutics's phone number is 18*********
Answer: Third Pole Therapeutics's official website is https://pole3.com
Answer: Third Pole Therapeutics's revenue is $10 Million to $25 Million
Answer: Third Pole Therapeutics's SIC: 2834
Answer: Third Pole Therapeutics's NAICS: 541720
Answer: Third Pole Therapeutics has 11-50 employees
Answer: Third Pole Therapeutics is in Medical Devices
Answer: Third Pole Therapeutics top competitors include: Abiomed , Insulet Corporation , Medtronic
Answer: Third Pole Therapeutics contact info: Phone number: 18********* Website: https://pole3.com
Answer: Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our teams legacy in inhaled nitric oxide (NO), the current standard of care, to develop next generation life-saving heart and lung therapies. Our first product is being designed to be a simple, convenient, economical, and lightweight device capable of generating nitric oxide from air on-demand and on-site which potentially eliminates the need for large compressed gas cylinders. We believe our novel approach of creating NO on demand has the promise to create new markets by enabling the worldwide use of inhaled NO in settings outside of acute care.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month